Seres Therapeutics Reports Third Quarter 2015 Financial Results And Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics Inc. (NASDAQ: MCRB), a leading microbiome therapeutics platform company, today reported financial results and provided a business update for the third quarter ended September 30, 2015.
“Over the past few months, we have continued to make significant progress in the microbiome space by advancing our promising pipeline of Ecobiotic® therapeutics,” said Roger Pomerantz, M.D., President, CEO and Chairman of Seres.
Help employers find you! Check out all the jobs and post your resume.
“Over the past few months, we have continued to make significant progress in the microbiome space by advancing our promising pipeline of Ecobiotic® therapeutics,” said Roger Pomerantz, M.D., President, CEO and Chairman of Seres.
Help employers find you! Check out all the jobs and post your resume.